Whole pelvis radiotherapy for pathological node-positive prostate cancer : Oncological outcome and prognostic factors.

about

Postoperative radiotherapy for prostate cancer : Morbidity of local-only or local-plus-pelvic radiotherapy.

P2860

Q50002077-FAAFAFBC-4512-4F14-A775-3F9A3BE259EE

P2860

Whole pelvis radiotherapy for pathological node-positive prostate cancer : Oncological outcome and prognostic factors.

Item

http://www.wikidata.org/entity/Q40374061

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Whole pelvis radiotherapy for ...... utcome and prognostic factors.

@en

type

Item

label

Whole pelvis radiotherapy for ...... utcome and prognostic factors.

@en

prefLabel

Whole pelvis radiotherapy for ...... utcome and prognostic factors.

@en

P1476

Whole pelvis radiotherapy for ...... outcome and prognostic factors

@en

P2093

Bart De Troyer

http://www.w3.org/2001/XMLSchema#string

Gert De Meerleer

http://www.w3.org/2001/XMLSchema#string

Karel Decaestecker

http://www.w3.org/2001/XMLSchema#string

Nicolaas Lumen

http://www.w3.org/2001/XMLSchema#string

Piet Ost

http://www.w3.org/2001/XMLSchema#string

Pieter De Visschere

http://www.w3.org/2001/XMLSchema#string

Tom Claeys

http://www.w3.org/2001/XMLSchema#string

Valérie Fonteyne

http://www.w3.org/2001/XMLSchema#string

P2860

Prognostic factors and survival in node-positive (N1) prostate cancer-a prospective study based on data from a Swedish population-based cohort.

Failure-Free Survival and Radiotherapy in Patients With Newly Diagnosed Nonmetastatic Prostate Cancer: Data From Patients in the Control Arm of the STAMPEDE Trial.

Adjuvant androgen deprivation for high-risk prostate cancer after radical prostatectomy: SWOG S9921 study

Quantifying the evidence for the risk of metabolic syndrome and its components following androgen deprivation therapy for prostate cancer: a meta-analysis.

Surveillance or metastasis-directed Therapy for OligoMetastatic Prostate cancer recurrence (STOMP): study protocol for a randomized phase II trial

Favorable outcomes in locally advanced and node positive prostate cancer patients treated with combined pelvic IMRT and androgen deprivation therapy

Immediate versus deferred androgen deprivation treatment in patients with node-positive prostate cancer after radical prostatectomy and pelvic lymphadenectomy.

A Contemporary Prostate Cancer Grading System: A Validated Alternative to the Gleason Score

The role of radical prostatectomy and lymph node dissection in lymph node-positive prostate cancer: a systematic review of the literature.

Emerging roles of radioresistance in prostate cancer metastasis and radiation therapy.

P2888

s00066-016-1094-5

P304

444-451

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00066-016-1094-5

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

193

http://www.w3.org/2001/XMLSchema#string

P50

Bert Dhondt

Filip Poelaert

P577

2017-01-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28101585

http://www.w3.org/2001/XMLSchema#string

Whole pelvis radiotherapy for pathological node-positive prostate cancer : Oncological outcome and prognostic factors.

about

P2860

P2860

Whole pelvis radiotherapy for pathological node-positive prostate cancer : Oncological outcome and prognostic factors.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698